Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | — | 580.1B | 549.0B | 556.5B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | -12.3B | 19.2B | -20.9B |
Other operating expenses | — | -4.4B | 9.0B | -7.8B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | 1.2B | 1.1B | 1.2B |
Other income expense | — | -32.8B | 9.9B | -69.7B |
Pretax income | 25.7B | 111.1B | 66.6B | 171.5B |
Tax provision | 6.3B | 28.3B | 17.0B | 18.3B |
Net income | 19.4B | 82.7B | 49.6B | 153.2B |
Basic EPS | 276.7 | — | 709 | — |
Diluted EPS | 276.7 | — | 709 | — |
Basic average shares | — | — | 69.9M | — |
Diluted average shares | — | — | 69.9M | — |
EBITDA | — | — | — | — |
Net income from continuing op. | — | 82.7B | — | 153.2B |
Minority interests | -53.5M | 93.0M | -57.3M | -40.4M |
Preferred stock dividends | — | — | — | — |